Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by daydream1on Aug 13, 2012 2:01pm
254 Views
Post# 20211780

RE: RE: RE: RE: And You Thought The Car Guys Were

RE: RE: RE: RE: And You Thought The Car Guys Were

It’s all in the delivery. Our Bio frustrated friend should had formulated its request for some of the long time holder to sell out; as to sell out one’s shares at these bottom price so one can make use of capital loss (assuming said long shareholder has bought at a much higher price) and buy back after 30 days. The sell off at the beginning of the month was just that.

If you had read NRI’s outlook and up coming milestone with a mind willing to appreciate what was stated by NRI you could had concluded that as of the end of July until some time in Sept where an announcement on Pliaglis is due from the FDA there is not much that will make the stock price move. From that time on, until March 4 2013 NRI if lucky should attain it’s full potential. Whatever, that full potential is it will certainly be a few multiples of the present share price. Therefore, selling at the end of July or beginning of August and buy back at the end of August to early Sept would had been a wise move to maximise your losing investment in NRI (if you believe NRI will ever again value that is). When there is an option the act, it always better to be pro-active rather than sit back and wait for things to change for the better.

Maximise your lost to make more money....

 

Goodluck

D.

Bullboard Posts